|
|
||
| |
128 Venture Capital Group 3i Venture Capital Accuitive Medical Acer Venture Capital Act Venture Capital Ltd Adelaide Venture Capital Email ADS Ventures Boston Advantages Of Venture Capital Advent Venture Capital Agio Capital Alabama Venture Capital Alaska Venture Capital All Stages Venture Capital American Venture Capital Analysis Venture Capital Analyze Venture Capital Angel Capital Appraisal Venture Capital Arch Venture Capital Argentina Venture Capital Arizona Venture Capital Arkansas Venture Capital Arrowpath Venture Capital Assess Venture Capital Assessment Venture Capital Atlas Venture Capital ATV Venture Capital Aurora Fund Australia Venture Capital Austria Venture Capital Automotive Venture Capital AZ Venture Capital VCgate More Tags
-
GE Healthcare Financial Services and BlueCrest Capital Finance Close a $27.5 Million Financing with SkinMedica, Inc.
CHICAGO. GE Healthcare Financial Services, as agent, along with co-lender BlueCrest Capital Finance have provided a $27.5 million senior secured credit facility to SkinMedica, Inc., a leading specialty pharmaceutical company focused on developing, acquiring, and commercializing products that treat dermatologic conditions and diseases and improve the appearance of skin.
The credit facility consists of a $22.5 million venture loan and a $5 million revolving credit line. SkinMedica will use the financing for general corporate purposes as well as to strengthen its balance sheet.
For almost two decades, the life science finance team of GE Healthcare Financial Services has worked with more than 500 companies throughout the United States, Canada and Europe. With a dedicated focus on assisting life science companies large and small, from the first venture round to post-IPO, the team has provided over $2.5 billion in financing to the market.
About SkinMedica
SkinMedica is a specialty pharmaceutical company focused on developing, acquiring and commercializing products that treat dermatologic conditions and diseases and improve the appearance of skin. Through their own sales force, they market and sell primarily to dermatologists both prescription pharmaceutical products and physician-dispensed, non-prescription skin care products, which they refer to as cosmeceuticals.
The Company currently markets four pharmaceutical products: Desonate for the treatment of mild to moderate atopic dermatitis, VANIQA for the reduction in growth of unwanted facial hair in women, EpiQuin Micro for the treatment of hyperpigmentation and NeoBenz Micro for the treatment of acne. SkinMedica’s aesthetic products, including their flagship product TNS Recovery Complex, are designed to enhance skin appearance, reduce signs of aging and provide other skin care benefits.
SkinMedica’s investors include Domain Associates, Apax Partners, Perseus-Soros Biopharmaceutical Fund, Healthcare Ventures, EuclidSR Partners and Montagu Newhall.
About BlueCrest Capital Finance, L.P.
BlueCrest Capital Finance, L.P., a US based commercial finance company, provides debt financing solutions to development stage companies in a broad range of industry sectors including IT, Communications, Hardware, Software, Semi-Conductor, Electronics, Energy, Medical Device and Life Science. The team, which has been together continuously since 1998, pursues debt transactions in the $1-25 million range and has consummated approximately 900 transactions with total commitments in excess of $1.9 billion.
About GE Healthcare Financial Services
GE Healthcare Financial Services is the premier provider of capital, financial solutions, and related services for the global healthcare market. With approximately $22 billion in assets, GE Healthcare Financial Services offers a full range of financing capabilities from equipment leasing and real estate financing to working capital lending, vendor programs, and acquisition financing. With a dedicated focus and a deep knowledge of the healthcare industry, GE Healthcare Financial Services collaborates with customers to create tailored financial solutions that help them improve their productivity and profitability.
Leave a reply
Latest Headlines:
Saturday July 24, 2010
Investors Show Interest in Trillion Dollar Outdoor Lifestyles Industry as NBFog Closes Bridge Funding Round
Thursday July 22, 2010
Euthymics Biosciences Closes $24 Million in Series A Funding and Acquires DOV Pharmaceutical
Thursday July 22, 2010
MK Capital Leads $8 Million in Series C Funding for TopSchool
Wednesday July 21, 2010
NGP Energy Technology Partners Leads Undisclosed Dollar Amount in Series D Funding Round for LedEngin
Tuesday July 20, 2010
Santé Ventures Leads $6 Million in Series B Funding for EndoStim
Friday July 16, 2010
Round Table Healthcare Partners Closes $600 Million Equity Fund and $200 Million Capital Fund
Friday July 16, 2010
Trilliant Raises $106 Million in Growth Capital, Funding Round Led by Investor Growth Capital, Vantage Point, ABB, and GE
Thursday July 15, 2010
Polaris Venture Partners and New Enterprise Associates Lead $35 Million in Series B Funding for Travena
Bad Behavior has blocked 382 access attempts in the last 7 days.
